Skip to main content
26 April 2024
Last updated:
Thursday 25 April 2024
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Antibody
Antibody
The perilous state of antibiotic development
Read more
Advancing a modular approach to antibody design
Read more
Antibodies show promise against influenza
Read more
Developing biosimilar monoclonal antibodies will not be easy
Read more
Symphogen sees opportunities in antibody mixtures
Read more
ArGEN-X builds a new antibody business
Read more
EMA guidance on biosimilar monoclonal antibodies
Read more
Affimed brings new antibody to the clinic
Read more
Intercell invests in antibody technology
Read more
Getting in the loop with Bicycle Therapeutics
Read more
Pagination
Previous page
‹‹
Page 3
Next page
››
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form